TY  - GEN
AU  - Gooderham,M
AU  - Elewski,B E
AU  - Pariser,D M
AU  - Sofen,H
AU  - Mendelsohn,A M
AU  - Rozzo,S J
AU  - Li,Q
TI  - Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis: Letter to the Editor
SN  - 1468-3083
PY  - 2020///0402
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Dermatologic Agents
KW  - Gastrointestinal Tract
KW  - drug effects
KW  - Humans
KW  - Incidence
KW  - Psoriasis
KW  - drug therapy
N1  - Publication Type: Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/jdv.15643
ER  -